At 24 h post-chemotherapy, the number of WT AML blasts in the BM was reduced by three-fold, while Selplg–/– AML blast burden had reduced by seven-fold – when compared to matched no-chemotherapy (saline-treated) leukemic mice. The gene discussed is SELPLG; the disease is acute myeloid leukemia.